Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Novel Use and Method of Rapamycin To Treat Toxic Shock, 50960 [E9-23770]

Download as PDF 50960 pwalker on DSK8KYBLC1PROD with NOTICES ACTION: Federal Register / Vol. 74, No. 190 / Friday, October 2, 2009 / Notices Notice of open meeting. DEPARTMENT OF DEFENSE SUMMARY: In accordance with Section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92–463), announcement is made of the following committee meeting: Name of Committee: Department of the Army Historical Advisory Committee. Date: October 22, 2009. Time: 9 a.m. to 4:30 p.m. Place: U.S. Army Center of Military History, Collins Hall, Building 35, 103 Third Avenue, Fort McNair, DC 20319– 5058. Proposed Agenda: Review and discussion of the status of historical activities in the United States Army. FOR FURTHER INFORMATION CONTACT: Dr. Richard Stewart, U.S. Army Center of Military History, ATTN: AAMH–ZC, 103 Third Avenue, Fort McNair, DC 20319–5058; telephone number (202) 685–2709. SUPPLEMENTARY INFORMATION: The committee will review the Army’s historical activities for FY 2009 and those projected for FY 2010 based upon reports and manuscript received throughout the period. And the committee will formulate recommendations through the Chief of Military History to the Chief of Staff, Army, and the Secretary of the Army for advancing the use of history in the U.S. Army. The meeting of the advisory committee is open to the public. Because of the restricted meeting space, however, attendance may be limited to those persons who have notified the Advisory Committee Management Office in writing at least five days prior to the meeting of their intention to attend the October 22, 2009, meeting. Notifications should be addressed to the Executive Secretary of the committee, Dr. William Stivers, at the U.S. Army Center of Military History, 103 Third Avenue, Fort Lesley J. McNair, DC 20319–5058. Any member of the public may file a written statement with the committee before, during, or after the meeting. Such statements may be sent to the Executive Secretary of the committee at the address shown in the paragraph above. To the extent that time permits, the committee chairman may allow public presentations or oral statements at the meeting. Dated: September 21, 2009. Richard W. Stewart, Chief Historian, Center of Military History. [FR Doc. E9–23771 Filed 10–1–09; 8:45 am] BILLING CODE 3710–08–P VerDate Nov<24>2008 16:40 Oct 01, 2009 Jkt 220001 Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Novel Use and Method of Rapamycin To Treat Toxic Shock Department of the Army, DoD. Notice. AGENCY: ACTION: SUMMARY: Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/ 231,348 entitled ‘‘Novel Use and Method of Rapamycin to Treat Toxic Shock,’’ filed August 5, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Assessment, (301) 619–6664, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: The invention relates to the use of Rapamycin as a treatment of toxic shock induced by staphylococcal exotoxins; more specifically, staphylococcal enterotoxins that are potent activators for human T cells and can cause lethal shock. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. E9–23770 Filed 10–1–09; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Monoclonal Antibodies Against Glycoprotein of Ebola Sudan Boniface Virus Department of the Army, DoD. Notice. AGENCY: ACTION: SUMMARY: Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/ PO 00000 Frm 00015 Fmt 4703 Sfmt 4703 239,266 entitled ‘‘Monoclonal Antibodies Against Glycoprotein of Ebola Sudan Boniface Virus,’’ filed September 2, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: Commander, U.S. Army Medical Research and Material Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Assessment, (301) 619–6664, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: The invention relates generally to the field of antibodies. More specifically the invention relates to monoclonal antibodies against glycoproteins of the Ebola Sudan Boniface virus and methods of producing and using the same. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. E9–23769 Filed 10–1–09; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF EDUCATION Submission for OMB Review; Comment Request Department of Education. The Director, Information Collection Clearance Division, Regulatory Information Management Services, Office of Management invites comments on the submission for OMB review as required by the Paperwork Reduction Act of 1995. DATES: Interested persons are invited to submit comments on or before November 2, 2009. ADDRESSES: Written comments should be addressed to the Office of Information and Regulatory Affairs, Attention: Education Desk Officer, Office of Management and Budget, 725 17th Street, NW., Room 10222, New Executive Office Building, Washington, DC 20503, be faxed to (202) 395–5806 or send e-mail to oira_submission@omb.eop.gov. AGENCY: SUMMARY: Section 3506 of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35) requires that the Office of Management and Budget (OMB) provide interested Federal agencies and the public an early SUPPLEMENTARY INFORMATION: E:\FR\FM\02OCN1.SGM 02OCN1

Agencies

[Federal Register Volume 74, Number 190 (Friday, October 2, 2009)]
[Notices]
[Page 50960]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-23770]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Provisional Patent Application Concerning Novel Use 
and Method of Rapamycin To Treat Toxic Shock

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Provisional Patent Application Serial No. 
61/231,348 entitled ``Novel Use and Method of Rapamycin to Treat Toxic 
Shock,'' filed August 5, 2009. The United States Government, as 
represented by the Secretary of the Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Assessment, (301) 619-6664, 
both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to the use of 
Rapamycin as a treatment of toxic shock induced by staphylococcal 
exotoxins; more specifically, staphylococcal enterotoxins that are 
potent activators for human T cells and can cause lethal shock.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. E9-23770 Filed 10-1-09; 8:45 am]
BILLING CODE 3710-08-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.